Gastrointestinal CancerFactors associated with anal cancer screening uptake in men who have sex with men living with HIV a cross-sectional studyVanhaesebrouck, Alexisa; Pernot, Simonb,,e; Pavie, Juliettec; Lucas, Marie-Laurec; Collias, Lioc; Péré, Hélèned,,e; Taieb, Julienb,,e; Weiss, Laurencec,,e,,*; Grabar, Sophiea,,e,,*Author Information aDepartment of Biostatistics and Epidemiology, Cochin Hôtel-Dieu Hospital Departments of bHepatogastroenterology and Digestive Oncology cClinical Immunology dVirology, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (APHP) eParis Descartes University, Sorbonne Paris Cité University, Paris, France Received 3 August 2018 Accepted 6 February 2019 * Laurence Weiss and Sophie Grabar contributed equally to the writing of this article. Presented in part at the European Society For Medical Oncology (ESMO) Annual Congress; 7–11 October 2016; Copenhagen, Denmark. Correspondence to Alexis Vanhaesebrouck, MD, Department of Biostatistics and Epidemiology, Cochin Hôtel-Dieu Hospital, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France, Tel: + 33 158 411 682; e-mail: firstname.lastname@example.org European Journal of Cancer Prevention: January 2020 - Volume 29 - Issue 1 - p 1–6 doi: 10.1097/CEJ.0000000000000507 Buy Metrics Abstract Most western countries have guidelines on anal cancer screening for men who have sex with men (MSM) living with HIV. However, adherence to these guidelines has been studied poorly. This cross-sectional study reports anal cancer screening uptake and identifies the factors associated with a previous screening in MSM living with HIV in a Paris Hospital (France). A total of 410 outpatients completed a self-administered questionnaire on anal cancer screening. The median age was 50 years and the median time from HIV diagnosis was 14.2 years. Overall, 82.2% of patients were aware of anal cancer screening and, of these, 56.7% had already undergone a screening test. The absence of history of screening (43.3%) was most often explained by lack of time (31.3%) or information (28.2%). Among patients familiar with the anal screening procedure, those older than 50 years (adjusted odds ratio=2.4, 95% confidence interval=1.3–4.7, P=0.007) and informed by healthcare providers (adjusted odds ratio=8.2, 95% confidence interval=2.5–32.0, P=0.001) were more likely to have already been screened. To date, adherence to anal cancer screening in MSM living with HIV appears to be inadequate to enable diagnosis of cancer at its early stages. Encouraging physicians to inform MSM living with HIV about anal cancer screening, irrespective of their age, could be an effective strategy to improve anal cancer screening uptake. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.